Загрузка...
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma
INTRODUCTION: Patients with advanced hepatocellular carcinoma have a dismal prognosis; only a subset of patients with advanced HCC will benefit from treatment with immunotherapy. We searched for clinical characteristics predicting exceptional long-term survival in HCC patients treated with immune ch...
Сохранить в:
| Опубликовано в: : | J Hepatocell Carcinoma |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178695/ https://ncbi.nlm.nih.gov/pubmed/34104639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S311496 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|